← All Puma Biotechnology, INC filings

Puma Biotechnology, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
PBYI
Puma Biotechnology, INC
DEF: Puma Biotechnology Sets Annual Meeting, Proposes Director Elections and Warrant Extension
Puma Biotechnology, Inc. has announced its 2026 annual meeting of stockholders, scheduled for June 11, 2026, to elect directors, ratify auditors, and vote on executive compensation and an extension of CEO Alan H. Auerbach's warrant.
NASDAQ
PBYI
Puma Biotechnology, INC
DEFA14A: Puma Biotechnology Files Definitive Proxy Statement with SEC
Puma Biotechnology has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
PBYI
Puma Biotechnology, INC
DEF: Puma Biotechnology Announces Annual Meeting of Stockholders, Director Nominations and Executive Compensation Details
Puma Biotechnology's proxy statement details the agenda for the 2025 annual meeting, including director elections, auditor ratification, and an advisory vote on executive compensation.
NASDAQ
PBYI
Puma Biotechnology, INC
DEFA14A: Puma Biotechnology Files Definitive Proxy Statement
Puma Biotechnology has filed a definitive proxy statement with the SEC.
NASDAQ
PBYI
Puma Biotechnology, INC
DEF 14A: Puma Biotechnology Seeks Stockholder Approval for Amended Incentive Award Plan
Puma Biotechnology is asking stockholders to approve an amendment to its 2011 Incentive Award Plan to increase the number of shares available for issuance and extend the period for granting incentive stock options.